In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Keros Therapeutics (KROS – Research Report). The ...

Trimester, the University launches new degree and certificate programs in the areas of healthcare, legal, operations and ...

This year's Fujisankei Ladies Classic golf tournament, scheduled for April 25-27 in Shizuoka Prefecture, will be canceled, Japan LPGA Tour sources said Wednesday. Main tournament sponsor Fuji ...

"The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of ...

Bryan Supran, non-executive director and representative of Pfizer, stepped down from the Haleon board of directors. Elizabeth Holmes, the disgraced founder of Theranos, will remain in prison after ...

AMMAN — Hikma Pharmaceuticals PLC posted 'robust' financial results for 2024, with revenue climbing 9 per cent to $3.127 billion compared to $2.875 billion in 2023, according to audited figures ...

The new regional registry for rare disease patients in Campania, inaugurated in January, the multidisciplinary ...

In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive ...

Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2024.

Privately-held BridGene Biosciences has announced a strategic collaboration and licensing agreement with Japan’s Takeda. The ...

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology. Takeda will pay ...